Poly Medicure Limited has informed the Exchange about Revised Investors Presentation

Poly Medicure has filed a revised investor presentation detailing its acquisition of Citieffe Group, an Italy-based maker of trauma and extremity bone-fixation products founded in 1962. The deal involves buying 100% of Medistream SA (which includes Citieffe SRL and its US/Mexico subsidiaries) from European healthcare PE fund Archimed, for an equity value of about EUR 18.8 million, plus EUR 4.2 million in shareholder loan repayments, totaling an upfront payout of around EUR 23 million. Total enterprise value is EUR 31 million, implying a multiple of 10.2x FY24 EBITDA. Citieffe reported CY24 revenue of EUR 17.3 million (up 15% YoY) and EBITDA of EUR 3.1 million (up 14% YoY), has 45 patents, full EU MDR clearance, and a #2 independent share in Italy and 12%+ share in Mexico. The acquisition will be funded entirely from Poly Medicure's existing cash and internal accruals, with closing expected in 4–8 weeks, and existing Citieffe management, including CEO Pascal Govi, will continue. The presentation also outlines synergy plans including product portfolio expansion (plates in near term, joint replacement medium term), introducing Citieffe products in India via Polymed's network, and scaling up the US business.